These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38913595)

  • 1. Influence of the glutamate-glutamine cycle on valproic acid-associated hepatotoxicity in pediatric patients with epilepsy.
    Ma L; Zhu J; Kong X; Chen L; Du J; Yang L; Wang D; Wang Z
    Clin Toxicol (Phila); 2024 Jun; 62(6):364-371. PubMed ID: 38913595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of glutamine synthetase gene polymorphisms on the development of hyperammonemia during valproic acid-based therapy.
    Inoue K; Takahashi T; Yamamoto Y; Suzuki E; Takahashi Y; Imai K; Inoue Y; Hirai K; Tsuji D; Itoh K
    Seizure; 2015 Dec; 33():76-80. PubMed ID: 26599579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in the susceptibility to valproic acid-associated liver injury in epileptic patients.
    Ma L; Wang D
    Clin Toxicol (Phila); 2024 Feb; 62(2):101-106. PubMed ID: 38512019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for Valproic Acid-induced Hyperammonaemia in Chinese Paediatric Patients with Epilepsy.
    Zhu X; Li X; Zhang T; Zhao L
    Basic Clin Pharmacol Toxicol; 2018 Nov; 123(5):628-634. PubMed ID: 29791065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes.
    Qi L; Qi Q; Prudente S; Mendonca C; Andreozzi F; di Pietro N; Sturma M; Novelli V; Mannino GC; Formoso G; Gervino EV; Hauser TH; Muehlschlegel JD; Niewczas MA; Krolewski AS; Biolo G; Pandolfi A; Rimm E; Sesti G; Trischitta V; Hu F; Doria A
    JAMA; 2013 Aug; 310(8):821-8. PubMed ID: 23982368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variants p.Q1236H and p.E1143G in mitochondrial DNA polymerase gamma POLG1 are not associated with increased risk for valproate-induced hepatotoxicity or pancreatic toxicity: A retrospective cohort study of patients with epilepsy.
    Hynynen J; Pokka T; Komulainen-Ebrahim J; Myllynen P; Kärppä M; Pylvänen L; Kälviäinen R; Sokka A; Jyrkilä A; Lähdetie J; Haataja L; Mäkitalo A; Ylikotila P; Eriksson K; Haapala P; Ansakorpi H; Hinttala R; Vieira P; Majamaa K; Rantala H; Uusimaa J
    Epilepsia; 2018 Nov; 59(11):2125-2136. PubMed ID: 30255931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalase C-262T Polymorphism Is a Risk Factor for Valproic Acid-Induced Abnormal Liver Function in Chinese Patients With Epilepsy.
    Ma L; Pan Y; Sun M; Shen H; Zhao L; Guo Y
    Ther Drug Monit; 2019 Feb; 41(1):91-96. PubMed ID: 30422963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients.
    Goto S; Seo T; Hagiwara T; Ueda K; Yamauchi T; Nagata S; Ando Y; Ishitsu T; Nakagawa K
    J Pharm Pharmacol; 2008 Feb; 60(2):267-72. PubMed ID: 18237476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of CYP2C9 and CYP2A6 Polymorphisms with the Concentrations of Valproate and its Hepatotoxin Metabolites and Valproate-Induced Hepatotoxicity.
    Zhao M; Zhang T; Li G; Qiu F; Sun Y; Zhao L
    Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):138-143. PubMed ID: 28273397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione-S-transferase (GST) M1 null genotype and combined GSTM1 and GSTT1 null genotypes are risk factors for increased serum gamma-glutamyltransferase in valproic acid-treated patients.
    Fukushima Y; Seo T; Hashimoto N; Higa Y; Ishitsu T; Nakagawa K
    Clin Chim Acta; 2008 Mar; 389(1-2):98-102. PubMed ID: 18155166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of CPS14217C>A genotype on valproic-acid-induced hyperammonemia.
    Yagi M; Nakamura T; Okizuka Y; Oyazato Y; Kawasaki Y; Tsuneishi S; Sakaeda T; Matsuo M; Okumura K; Okamura N
    Pediatr Int; 2010 Oct; 52(5):744-8. PubMed ID: 20456087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of carnitine supplementation during valproic acid therapy.
    Raskind JY; El-Chaar GM
    Ann Pharmacother; 2000 May; 34(5):630-8. PubMed ID: 10852092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Influencing Plasma Concentrations of Valproic Acid in Pediatric Patients With Epilepsy and the Clinical Significance of CYP2C9 Genotypes in Personalized Valproic Acid Therapy.
    Ma B; Yang K; Li X; Su N; Yu T; Zou Y; Xu X; Wang F; Cheng J; Yan Z; Chen T; Zhang L
    Ther Drug Monit; 2024 Aug; 46(4):503-511. PubMed ID: 38287884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients].
    Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C
    Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproic acid and fatalities in children: a review of individual case safety reports in VigiBase.
    Star K; Edwards IR; Choonara I
    PLoS One; 2014; 9(10):e108970. PubMed ID: 25302991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatotoxicity induced by valproic acid in adults. Report of 3 cases].
    Galdames D; Silva C; Aguilera L; Chesta J
    Rev Med Chil; 1993 Dec; 121(12):1432-6. PubMed ID: 8085069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs.
    Verrotti A; Greco R; Morgese G; Chiarelli F
    Int J Clin Lab Res; 1999; 29(1):36-40. PubMed ID: 10356662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproic Acid and the Liver Injury in Patients with Epilepsy: An Update.
    Guo HL; Jing X; Sun JY; Hu YH; Xu ZJ; Ni MM; Chen F; Lu XP; Qiu JC; Wang T
    Curr Pharm Des; 2019; 25(3):343-351. PubMed ID: 30931853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of age and polytherapy, risk factors of valproic acid (VPA) hepatotoxicity, on the excretion of thiol conjugates of (E)-2,4-diene VPA in people with epilepsy taking VPA.
    Gopaul S; Farrell K; Abbott F
    Epilepsia; 2003 Mar; 44(3):322-8. PubMed ID: 12614387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of GSTP1 rs1695 and CAT rs769217 with elevated AST induced by valproate sodium in Chinese children with epilepsy.
    Wang L; Li H; Zeng G; Shi L; Zhu M; Luo J; Zhang Z
    Pak J Pharm Sci; 2021 Sep; 34(5):1759-1766. PubMed ID: 34803013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.